Skip to main content
. 2019 Sep 17;6(4):543–557. doi: 10.1007/s40744-019-00173-8

Fig. 2.

Fig. 2

Subject disposition. AE adverse event, FAS full analysis set, PPP per protocol population, SAF safety analysis set, SUA serum uric acid